Individualized stress management for primary hypertension: a randomized trial

Archives of Internal Medicine
W LindenA H Con

Abstract

To test the efficacy of individualized stress management for primary hypertension in a randomized clinical trial with the use of ambulatory blood pressure (BP) measures. Men and women aged 28 to 75 years with mean ambulatory BP greater than 140/90 mm Hg received 10 hours of individualized stress management by means of semistandardized treatment components. They were randomly assigned to immediate treatment (n = 27) or a wait list control group (n = 33). Participants on the wait list were subsequently offered treatment. Six-month follow-up data were available from 36 of the 45 participants who completed treatment. Measures were 24-hour ambulatory BP, lipid levels, weight, and psychological measures. Blood pressure was significantly reduced in the immediate treatment group and did not change in control subjects (-6.1 vs +0.9 mm Hg for systolic and -4.3 vs +0.0 mm Hg for diastolic pressure). When the wait list control group was later treated, BP was similarly reduced by -7.8 and -5.2 mm Hg, and for the combined sample, total change at follow-up was -10.8 and -8.5 mm Hg. Level of BP at the beginning of treatment was correlated with BP change (r = 0.45 [P<.001] and 0.51 [P<.001], respectively), and amount of systolic BP change was p...Continue Reading

Citations

Oct 16, 2013·Psychosomatic Medicine·Joel W HughesRichard Josephson
Jan 28, 2014·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·S C Manchanda, Kushal Madan
Apr 21, 2012·International Journal of Hypertension·Carly M GoldsteinJoel W Hughes
Aug 20, 2003·QJM : Monthly Journal of the Association of Physicians·A Schattner
Jan 21, 2006·Journal of General Internal Medicine·Karen B DeSalvoJohn Peabody
Aug 6, 2003·Emotion·Wolfgang LindenDebbie Leung
Feb 26, 2004·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Brenda E Hogan, Wolfgang Linden
Aug 16, 2005·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Kristen M RabineauDavid Ludwig
Jun 21, 2003·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Rollin McCratyDana Tomasino
Mar 28, 2006·Applied Psychophysiology and Biofeedback·Wolfgang Linden, Janine V Moseley
Apr 20, 2005·Contemporary Clinical Trials·Hayden B BosworthEugene Z Oddone
Jun 8, 2007·Journal of Abnormal Child Psychology·Anne C MiersWolfgang Linden
Nov 27, 2002·The American Journal of the Medical Sciences·Molly I Szerlip, Harold M Szerlip
Dec 16, 2004·The Journal of Clinical Hypertension·Norman M Kaplan
Sep 18, 2014·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Christina GentileBianca D'Antono
Mar 8, 2003·Preventive Cardiology·Wolfgang Linden
Jan 6, 2005·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Kathleen M Wesa, Richard H Grimm
Apr 24, 2013·Hypertension·Robert D BrookUNKNOWN American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Council on Card
Dec 11, 2008·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Wolfgang LindenMelanie Phillips
Jan 5, 2006·Sleep & Breathing = Schlaf & Atmung·Ryo OtsukaFrank Ryan
Feb 7, 2008·The Cochrane Database of Systematic Reviews·Heather O DickinsonJames M Mason
Oct 3, 2002·Current Opinion in Cardiology·Michel SlamaEdward D Frohlich
Sep 12, 2018·Translational Behavioral Medicine·Lynn P ClemowWilliam Gerin
Apr 24, 2007·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Wolfgang Linden, Jillian R Satin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.